跳至主要内容
临床试验/IRCT20200410047009N1
IRCT20200410047009N1招募中4 期

Evaluation of the role of naproxen as adjunctive therapy with standard therapies and its efficacy in the early improvement and reduced mortality rate of COVID-19 patients

Iran University of Medical Sciences0 个研究点目标入组 101 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
入组人数
101

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Patients whose SARS-CoV-2 infection has been confirmed using PCR
  • Age over 18 years
  • The conscious consent form must be completed and signed by the patient or his companion
  • The patient should participate in the research voluntarily

排除标准

  • High creatinine and kidney problems
  • In gastrointestinal ulcers
  • Other conditions of contraindications to the use of Naproxen

研究者

相似试验